Skinvisible Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Skinvisible Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011799
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Skinvisible Pharmaceuticals Inc (Skinvisible Pharmaceuticals), a subsidiary of Skinvisible Inc is a pharmaceutical company that develops and manufactures prescription and over the counter dermatology, medical, cosmetic, consumer goods, and skincare products. The company’s products include anti-aging products, pre-surgical preparations, acne moisturizer, anti-itch spray, foot cream and spray, sunburn relief, antimicrobial hand sanitizing lotions, anti- inflammatory products, topical analgesics and first aid, among others. It uses invisicare technology for topical and mucosal products that binds ingredients to the skin and enhances their delivery. Skinvisible Pharmaceuticals conducts in-house research, development and testing of its invisicare polymer delivery vehicles. It serves pharmaceutical, skincare, cosmetic and consumer goods companies. Skinvisible Pharmaceuticals is headquartered in Las Vegas, Nevada, the US.

Skinvisible Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Merger 10
Skinvisible Pharma Plans to Merge with Quoin Pharma 10
Licensing Agreements 11
Canopy Growth Enters into License Agreement with Skinvisible Pharma 11
CannaSkin Enters into Licensing Agreement with Skinvisible Pharma 12
Skinvisible Pharmaceuticals Inc – Key Competitors 13
Skinvisible Pharmaceuticals Inc – Key Employees 14
Skinvisible Pharmaceuticals Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
Jul 07, 2017: Skinvisible Improves the Delivery of Cannabis with Patented Invisicare Technology 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Skinvisible Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Skinvisible Pharma Plans to Merge with Quoin Pharma 10
Canopy Growth Enters into License Agreement with Skinvisible Pharma 11
CannaSkin Enters into Licensing Agreement with Skinvisible Pharma 12
Skinvisible Pharmaceuticals Inc, Key Competitors 13
Skinvisible Pharmaceuticals Inc, Key Employees 14

★海外企業調査レポート[Skinvisible Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wallenstam AB (WALL B):企業概要、財務及び戦略的SWOT分析
    Summary Wallenstam AB (Wallenstam) is a property management service provider. The company builds, develops and manages residential and commercial properties. It also produces green electricity by using wind turbines. Wallenstam owns a total of about 250 properties and about 1,000 companies. The comp …
  • Gamma Medica Inc:企業のM&A・提携動向(医療機器分野)
    Summary Gamma Medica Inc (Gamma Medica), formerly Gamma Medica-Ideas, Inc. is a medical device company that offers imaging solutions. The company designs, develops and manufactures imaging systems for clinical and pre-clinical applications. It offers molecular breast imaging system, which detects ea …
  • BioCision LLC-製薬・医療分野:企業M&A・提携分析
    Summary BioCision LLC (BioCision) is a life science research and development company that develops products and solutions for process standardization. The company’s products include cell cryopreservation systems, ice-free cooling systems, tube and plate temperature management systems, cell thawing s …
  • Saudi vitrified clay pipes co.の企業概要及び財務/SWOT分析
    Saudi vitrified clay pipes co. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and …
  • Nuance Communications, Inc. (NUAN)-医療機器分野:企業M&A・提携分析
    Summary Nuance Communications, Inc. (Nuance) is a provider of speech and imaging solutions. It offers solutions such as automated speech recognition, dialog management, capabilities for natural language understanding, optical character recognition (OCR), domain knowledge and implementation capabilit …
  • Dubai Refreshments (P.S.C.):企業の戦略・SWOT・財務分析
    SummaryDubai Refreshments (P.S.C.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • pSivida Corp. (PSDV):企業概要、財務及び戦略的SWOT分析
    Summary pSivida Corp. (pSivida) is a drug researcher and developer. The company provides miniaturized and sustained release drug delivery products. Its products include Iluvien, Retisert and Durasert. pSivida’s Durasert is a miniaturized, injectable, sustained-release drug delivery system, which is …
  • 20 Microns Limited (20MICRONS):企業概要、財務及び戦略的SWOT分析
    Summary 20 Microns Limited (20 Microns) is a chemical company. The company produces and markets white minerals in the field of functional fillers, extenders and specialty chemicals. It operates through its product segments such as micronized minerals and specialty chemicals. 20 Microns’ products por …
  • La-Z-Boy Inc (LZB):企業の財務・戦略的SWOT分析
    La-Z-Boy Inc (LZB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Zimmer Biomet Holdings, Inc. (formerly Zimmer Holdings, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Zimmer Biomet Holdings, Inc. (f …
  • Trilogy Health Services LLC:企業のM&A・提携動向(医療分野)
    Summary Trilogy Health Services LLC (Trilogy) is a healthcare service provider that provides senior living and long-term healthcare services to residents, employees and communities. The center provides services such as independent living, assisted living, skilled nursing, memory care, rehabilitation …
  • Rallis India Ltd (RALLIS):企業財務及び戦略的SWOT分析
    Summary Rallis India Ltd (Rallis), a subsidiary of Tata Chemicals Ltd is an agrochemical company that provides chemicals and agri-solutions. The company operates through its business divisions such as domestic crop protection, international business, contract manufacturing, seeds, plant growth nutri …
  • The Zumtobel Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Zumtobel Group Mergers and …
  • Gulf Finance House:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gulf Finance House Mergers and …
  • American Green Group, Inc. (formerly Regions Oil and Gas, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' American Green Group, Inc. (for …
  • Compagnie Ivoirienne d’Electricite (CIEC):企業財務及び戦略的SWOT分析
    Summary Compagnie Ivoirienne d'Electricite (CIE), a subsidiary of Eranove is an electricity services company that offers power generation, transmission, and distribution services. The company offers exporting, importing and marketing of electricity. It also offers operation and management of hydroel …
  • Kingboard Chemical Holdings Ltd. (148):企業概要、財務及び戦略的SWOT分析
    Summary Kingboard Chemical Holdings Ltd. (Kingboard Chemical) is a chemical company. The company manufactures and markets chemicals and laminates. Its laminate products include paper laminate, glass epoxy laminate, and upstream material. Kingboard Chemical supplies chemicals such as chemical refiner …
  • A/S Mons Bank (MNBA):企業の財務及び戦略的SWOT分析
    Summary A/S Mons Bank (Mons Bank) is a financial and banking service provider that provides private, investment, and profession banking services. The bank provides counselling, pension info, compensation tax, and insurance services. Mons Bank offers insurance for life, loss of earning capacity, crit …
  • HollyFrontier Corporation (formerly Holly Corporation):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' HollyFrontier Corporation (form …
  • BWP Trust:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "BWP Trust" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a stand …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆